RCT Metformin for Reduction of Gestational Diabetes Mellitus Effects (EMERGE)
A Randomised Placebo Controlled Trial of the Effectiveness of Early MEtformin in Addition to Usual Care in the Reduction of Gestational Diabetes Mellitus Effects (EMERGE)
Sponsor: Clinical Research Support Unit, University of Limerick
A PHASE3 clinical study on Gestational Diabetes, this trial is completed. The trial is conducted by Clinical Research Support Unit, University of Limerick and has accumulated 12 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Apr 2025 — Present [monthly]
Completed PHASE3
-
Feb 2025 — Apr 2025 [monthly]
Completed PHASE3
-
Sep 2024 — Feb 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Sep 2023 — Jul 2024 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
▶ Show 7 earlier versions
-
Mar 2023 — Sep 2023 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Jun 2022 — Mar 2023 [monthly]
Recruiting PHASE3
-
Jan 2021 — Jun 2022 [monthly]
Recruiting PHASE3
-
Oct 2019 — Jan 2021 [monthly]
Recruiting PHASE3
-
Jun 2018 — Oct 2019 [monthly]
Recruiting PHASE3
-
Oct 2017 — Jun 2018 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Jan 2017 — Oct 2017 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Clinical Research Support Unit, University of Limerick
- HRB Clinical Research Facility Galway
- Health Research Board, Ireland
- National University of Ireland, Galway, Ireland
- Portiuncula University Hospital
- University College Hospital Galway
- University Hospital of Limerick
- University Maternity Hospital Limerick
For direct contact, visit the study record on ClinicalTrials.gov .